XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 19,682 $ 5,875 $ 32,621 $ 10,437
General and administrative 4,917 3,745 8,712 6,820
Total operating expenses 24,599 9,620 41,333 17,257
Loss from operations (24,599) (9,620) (41,333) (17,257)
Other income net 2,972 1,254 5,052 2,365
Net loss $ (21,627) $ (8,366) $ (36,281) $ (14,892)
Net loss per share, basic $ (0.34) $ (0.19) $ (0.62) $ (0.34)
Net loss per share, diluted $ (0.34) $ (0.19) $ (0.62) $ (0.34)
Weighted average common shares outstanding, basic 63,801,792 43,897,603 58,677,749 43,897,603
Weighted average common shares outstanding, diluted 63,801,792 43,897,603 58,677,749 43,897,603
Comprehensive loss:        
Net Income (Loss) $ (21,627) $ (8,366) $ (36,281) $ (14,892)
Other comprehensive gain (loss):        
Unrealized gain (loss) on marketable securities (125) 12 (231) 43
Total other comprehensive gain (loss) (125) 12 (231) 43
Total comprehensive loss $ (21,752) $ (8,354) $ (36,512) $ (14,849)